Finns are also among the most screening friendly people!

Finland is not only the happiest country in the world.

Finns are also among the most screening friendly people!

Finland Cancer Screening Programmes

Finland is not only the happiest country in the world. Finns are also among the most screening‑friendly people! Participation rates in national cancer screening programmes are exceptionally high and reflect strong public trust and commitment to preventive health.

The Finnish Cancer Registry

The Finnish Cancer Registry has been a forerunner in conducting major screening studies. Before any new screening programme is implemented or changes are made to existing programmes, they are evaluated in pilot and modelling studies.

📊 Decades of screening expertise:

  • Cervical cancer screening began in 1963
  • Breast cancer screening data collected since 1987
  • Colorectal cancer screening data collected since the nationwide rollout in 2022

Screenings Evaluations

The Registry guides the implementation of all three programmes and evaluates screenings nationwide. The #EUCanScreen Joint Action is an excellent opportunity for the Finnish Cancer Registry to share best practices and learn from other EU countries in order to further improve cancer screening programmes.

Annual Reports

📘 Interested in a clear overview of screening participation, results, and changes in cancer incidence? The Annual Reports of the Cancer Screening Programmes provide a concise summary of screening activities.

🔗 Read more: https://cancerregistry.fi/reports-and-publications/annual-reports-of-cancer-screening-programmes/

#EUCanScreen #RegistryData #Registry #CancerScreening

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959